SUPRIYA.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 May 2024 @ 02:34):

Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide...

Stats
Today's Volume	204 701
Average Volume	627 878
Market Cap	32.68B
EPS	INR2.97 ( 2023-11-07 )
Last Dividend	INR0.600 ( 2023-09-15 )
Next Dividend	INR0 ( N/A )
P/E	27.18
ATR14	INR0.470 (0.12%)

Volume Correlation

Long: 0.01 (neutral)

Short: -0.46 (neutral)

Signal:(42.767) Neutral

Supriya Lifescience Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Supriya Lifescience Correlation - Currency/Commodity

0.28
( neutral )

0.21
( neutral )

0.46
( neutral )

0.31
( neutral )

-0.54
( weak negative )

-0.36
( neutral )

Supriya Lifescience Financials

Annual	2022
Revenue:	INR4.61B
Gross Profit:	INR2.80B (60.77 %)
EPS:	INR11.16

FY	2022
Revenue:	INR4.61B
Gross Profit:	INR2.80B (60.77 %)
EPS:	INR11.16

FY	2022
Revenue:	INR5.19B
Gross Profit:	INR2.89B (55.74 %)
EPS:	INR18.86

FY	2021
Revenue:	INR3.85B
Gross Profit:	INR2.34B (60.77 %)
EPS:	INR48.47

Financial Reports:

No articles found.

Supriya Lifescience Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.600 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0.600 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Supriya Lifescience Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.03 - low (34.06%) | Divividend Growth Potential Score: 3.57 - Decrease likely (28.61%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.600	2022-09-01
Last Dividend	INR0.600	2023-09-15
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	INR1.200	--
Avg. Dividend % Per Year	0.10%	--
Score	1.7	--
Div. Sustainability Score	4.03
Div.Growth Potential Score	3.57
Div. Directional Score	3.80	--

Next Divdend (Est)
(2024-07-01)

INR0.400 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

1.70

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2022	INR0.600	0.12%
2023	INR0.600	0.25%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SARDAEN.NS	Dividend Junior	2023-09-07	Annually	15	0.65%
MAGADSUGAR.NS	Dividend Junior	2023-07-13	Annually	7	1.78%
GMDCLTD.NS	Dividend Knight	2023-09-22	Annually	23	3.41%
ASTRAMICRO.NS	Dividend Junior	2023-08-23	Annually	20	0.49%
TITAN.NS	Dividend Junior	2023-07-13	Annually	20	0.35%
PETRONET.NS	Dividend Knight	2023-08-18	Semi-Annually	18	2.36%
JASH.NS	Dividend Junior	2023-09-22	Annually	7	0.57%
DBOL.NS	Dividend Junior	2023-06-23	Insufficient data to determine frequency	2	0.56%
SILINV.NS	Dividend Junior	2023-08-18	Annually	23	0.63%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.217	1.500	5.66	8.48	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.166	1.500	9.27	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	66.65	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.70	2.00	8.77	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.70	2.00	8.15	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.619	1.000	3.01	3.01	[0.2 - 0.8]
operatingProfitMarginTTM	0.298	1.000	6.04	6.04	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				4.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.44	1.000	7.33	0	[1 - 100]
returnOnEquityTTM	0.166	2.50	9.53	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.70	2.00	8.77	10.00	[0 - 30]
dividendYielPercentageTTM	0.146	1.500	6.35	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.70	2.00	8.77	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.672	1.500	-7.81	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0538	1.000	-1.156	0	[0.1 - 0.5]
Total Score				3.57

Supriya Lifescience

Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, antihypertensive, and anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals. The company was founded in 1987 and is headquartered in Mumbai, India.